Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 814 across all filing types
Latest filing 2023-06-30 Transaction in Own Shar…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 26/06/2023 - 30/06/2023
Transaction in Own Shares Classification · 19% confidence
2023-06-30 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. – Period 19/06/2023 – 23/06/2023
Transaction in Own Shares Classification · 100% confidence The document is titled "REPORT ON THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A." and details the number of treasury shares purchased, the consideration paid, and the resulting holding percentage over a specific period (June 19, 2023 – June 23, 2023). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2023-06-23 Italian
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 19/06/2023 - 23/06/2023
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE DI DIASORIN S.P.A.' (Weekly Information on the Share Buyback Program of DiaSorin S.p.A.). It details the number of shares purchased by the company during the period June 19, 2023, to June 23, 2023. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. Although it is a weekly report, the core subject is the share repurchase activity, making POS more specific than a general regulatory filing (RNS) or a capital change announcement (SHA).
2023-06-23 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. – Period 12/06/2023 – 16/06/2023
Transaction in Own Shares Classification · 19% confidence
2023-06-16 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 12/06/2023 - 16/06/2023
Regulatory Filings
2023-06-16 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. – Period 07/06/2023 – 09/06/2023
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement titled "REPORT ON THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A." for the period 07/06/2023 – 09/06/2023. It details the number of treasury shares purchased, the total consideration, and provides a breakdown of daily transactions. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2023-06-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.